Transgene Biotek Ltd — Important, 11-10-2025: Company Update

The company has informed the stock exchanges that the requirement to submit a Statement of Deviation or Variation for funds raised is not applicable for the quarter ended September 30. This is because Transgene Biotek did not conduct any public, rights, or preferential share issues during that period. This update signifies that the company did not raise fresh capital through these common equity financing routes in the last quarter, and therefore, does not need to report on how such proceeds were utilized or if there were any changes from their stated purpose.